Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials

被引：0
|
作者：
Julien Taieb
Fernando Rivera
Salvatore Siena
Meinolf Karthaus
Manuel Valladares-Ayerbes
Javier Gallego
Michael Geissler
Reija Koukakis
Gaston Demonty
Marc Peeters
机构：
[1] Georges Pompidou European Hospital and Sorbonne Paris Cité / Université Paris Descartes,Department of Hepatogastroenterology and GI Oncology
[2] Hospital Universitario Marqués de Valdecilla,Grande Ospedale Metropolitano Niguarda and Dipartimento di Oncologia e Emato
[3] Università degli Studi di Milano,Oncologia, Niguarda Cancer Center
[4] Städtisches Klinikum München,Biostatistics
[5] Virgen del Rocio Hospital,undefined
[6] Hospital General Universitario de Elche,undefined
[7] Klinikum Esslingen,undefined
[8] Amgen Ltd,undefined
[9] Amgen (Europe) GmbH,undefined
[10] Medical Development,undefined
[11] Antwerp University Hospital,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
Depth of response; Early tumour shrinkage; Metastatic colorectal cancer; Panitumumab; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：321 / 335
页数：14
相关论文
共 50 条
  • [1] Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials
    Taieb, Julien
    Rivera, Fernando
    Siena, Salvatore
    Karthaus, Meinolf
    Valladares-Ayerbes, Manuel
    Gallego, Javier
    Geissler, Michael
    Koukakis, Reija
    Demonty, Gaston
    Peeters, Marc
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (02) : 321 - 335
  • [2] Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials
    Julien Taieb
    Fernando Rivera
    Salvatore Siena
    Meinolf Karthaus
    Manuel Valladares-Ayerbes
    Javier Gallego
    Michael Geissler
    Reija Koukakis
    Gaston Demonty
    Marc Peeters
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 795 - 797
  • [3] Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials (vol 144, pg 321, 2018)
    Taieb, Julien
    Rivera, Fernando
    Siena, Salvatore
    Karthaus, Meinolf
    Valladares-Ayerbes, Manuel
    Gallego, Javier
    Geissler, Michael
    Koukakis, Reija
    Demonty, Gaston
    Peeters, Marc
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (04) : 795 - 797
  • [4] Assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer
    Kr, A.
    P, S. S.
    Kumar, R. C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] An exploratory study-level meta-analysis assessing the impact of early tumour shrinkage on overall survival in patients with RAS wild-type metastatic colorectal cancer receiving first-line treatment in three randomised panitumumab trials
    Rivera, F.
    Karthaus, M.
    Valladares-Ayerbes, M.
    Gallego, J.
    Koukakis, R.
    Demonty, G.
    Douillard, J. -Y.
    ANNALS OF ONCOLOGY, 2016, 27 : 114 - 114
  • [6] Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer
    Manca, Paolo
    Corallo, Salvatore
    Randon, Giovanni
    Lonardi, Sara
    Cremolini, Chiara
    Rimassa, Lorenza
    Bergamo, Francesca
    Antoniotti, Carlotta
    Smiroldo, Valeria
    Zaniboni, Alberto
    Murialdo, Roberto
    Tampellini, Marco
    Tomasello, Gianluca
    Clavarezza, Matteo
    Racca, Patrizia
    Antista, Maria
    Raimondi, Alessandra
    Prisciandaro, Michele
    Pagani, Filippo
    Palermo, Federica
    Greco, Francesca Gabriella
    Vaiani, Marta
    Di Bartolomeo, Maria
    de Braud, Filippo
    Calareso, Giuseppina
    Morano, Federica
    Pietrantonio, Filippo
    EUROPEAN JOURNAL OF CANCER, 2021, 144 : 31 - 40
  • [7] Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancer
    Douillard, Jean-Yves
    Siena, Salvatore
    Peeters, Marc
    Koukakis, Reija
    Terwey, Jan-Henrik
    Tabernero, Josep
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (10) : 1231 - 1242
  • [8] Impact of early tumour shrinkage (ETS) on overall survival (OS) in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) receiving first-line treatment in three randomised panitumumab trials: An exploratory study-level meta-analysis
    Karthaus, M.
    Rivera, F.
    Valladares-Ayerbes, M.
    Gallego, J.
    Koukakis, R.
    Demonty, G.
    Douillard, J. -Y
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 93 - 94
  • [9] Early tumour shrinkage, depth of response and survival outcomes for RAS wild-type metastatic colorectal cancer patients classified by baseline tumour load: Retrospective pooled analysis of panitumumab PRIME/PEAK studies
    Loupakis, F.
    Peeters, M.
    Geissler, M.
    Modest, D.
    Valladares-Ayerbes, M.
    Price, T.
    Burdon, P.
    Zhang, Y.
    Taieb, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S114 - S115
  • [10] The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer
    Battaglin, Francesca
    Puccini, Alberto
    Djaballah, Selma Ahcene
    Lenz, Heinz-Josef
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 5911 - 5924
12345